MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-26-0025828
Hi Tech Biosciences India Private Limited - pharma in Pune, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹41.75 Cr
▲ 24% YoY
Net profit · FY 2025
₹6.03 Cr
Net margin 14.4%
EBITDA · FY 2025
₹11.29 Cr
EBITDA margin 27%
Authorised capital
₹7 Cr
Registered with MCA
Paid-up capital
₹3.91 Cr
Issued & subscribed
Open charges
₹24.55 Cr
Satisfied ₹30.95 Cr
Company age
19 yrs
Est. 2007
Employees · EPFO
97
Provident fund records
About Hi Tech Biosciences India Private Limited
Data last updated:
Hi Tech Biosciences India Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 24 April 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24232PN2007PTC130033. Its GSTIN is 27AABCH8625A1ZV (Maharashtra).
The company has an authorised share capital of ₹7 Cr and a paid-up capital of ₹3.91 Cr. It was formerly known as Hitech Bio Sciences India Limited. It is led by directors Raghavendra Prabhakar Gaikaiwari (Managing Director) and Shilpa Anil Wagh (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Pune, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹41.75 Cr, a growth of 24% compared to the previous year. For the same year it recorded a net profit of ₹6.03 Cr (net margin 14.4%) and EBITDA of ₹11.29 Cr (EBITDA margin 27%). Revenue has grown at a compounded annual rate (CAGR) of 21% over three years and 17% over five years.
The company has about 97 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Hi Tech BioSciences India. As per MCA filings, the company has open charges of ₹24.55 Cr and satisfied charges of ₹30.95 Cr on record. Court records list 3 cases involving the company, including 1 filed by the company and 2 filed against it; 1 case is pending. The company has 9 deals on record (6 secondary share transfers, 3 funding rounds), with disclosed funding of ₹4.68 Cr; the latest was in March 2021. Its 8 peer companies in the Chemicals industry (API Manufacturers, Biosciences, Industrial Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 4 smaller; the largest is Shraddha Associates (Guj) Private Limited with revenue of ₹42.24 Cr. The company has 8 MSME Form 1 returns on record between 2014 and 2022, listing 213 overdue payments to 42 micro and small suppliers.
Hi Tech Biosciences India Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-26-0025828). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website htblindia.com.
Company details
CIN U24232PN2007PTC130033
Registration Number 130033
Incorporation Date 24 April 2007
ROC Pune
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MH-26-0025828
Name history
Hi Tech Biosciences India has undergone 2 name changes throughout its history. The company was previously known as Hitech Bio Sciences India Limited, and Hitech Bio Sciences India Private Limited. The current legal name is Hi Tech Biosciences India Private Limited.
| Company Name | Status |
|---|---|
| Hi Tech Biosciences India Private Limited | Current |
| Hitech Bio Sciences India Limited | Previous |
| Hitech Bio Sciences India Private Limited | Previous |
CIN history
Hi Tech Biosciences India has one previous CIN (Corporate Identification Number): U24232PN2007PLC130033. The current CIN is U24232PN2007PTC130033, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232PN2007PTC130033 | Current |
| U24232PN2007PLC130033 | Previous |
Recognitions & Rankings of Hi Tech Biosciences India
Contact details
Hi Tech Biosciences India Private Limited's registered office is in Pune, Maharashtra. Its website is htblindia.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressC – 2 Unit No. 102103 Saudamini Complex S.No.101/1 Bhusari Colony Paud Road Ko, Thrud, Pune, Maharashtra, India – 411038
- IndustryPharma, API Manufacturers
To see the full contact details of Hi Tech Biosciences India Private Limited, buy the company report.
Comprehensive company report
Hi Tech Biosciences India Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Hi Tech Biosciences India operates one associated brand: Hi Tech BioSciences India. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Microbiomes for human, animal, poultry, and aquaculture use | htblindia.com |
Business activity
The main business activity of Hi Tech Biosciences India is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Hi Tech Biosciences India Private Limited, buy the company report.
Financials of Hi Tech Biosciences India Private Limited
FY 2025 filings availableHi Tech Biosciences India Private Limited reported revenue of ₹41.75 Cr (up 24% YoY) for FY 2025.
Revenue · FY 2025
₹41.75 Cr ▲ 24%
Net profit · FY 2025
₹6.03 Cr margin 14.4%
EBITDA · FY 2025
₹11.29 Cr margin 27%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 24%
3 years · compounded
▲ 21%
5 years · compounded
▲ 17%
EBITDA CAGR growth
1 year
▲ 108%
3 years · compounded
▲ 38%
5 years · compounded
▲ 25%
Revenue has grown at a compounded annual rate (CAGR) of 17% over five years, including 24% growth in the latest year. EBITDA rose 108% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹11.29 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹6.03 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 27% | ||||
| Net Profit Margin | 14.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Hi Tech Biosciences India Private Limited, buy the company report.
Board of directors of Hi Tech Biosciences India Private Limited
Hi Tech Biosciences India has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Raghavendra Prabhakar Gaikaiwari | Managing Director | 24 Apr 2007 | 19 Years 6 Months | Current |
| Shilpa Anil Wagh | Whole-Time Director | 27 Oct 2012 | 14 Years 0 Months | Current |
Peer comparison
Hi Tech Biosciences India Private Limited is compared with the 8 companies closest to it by revenue in the Chemicals industry (API Manufacturers, Biosciences, Industrial Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Shraddha Associates (Guj) Private Limited | ₹42.24 Cr (FY 2025) | -4.0% | Ahmedabad, Gujarat, India | |||
| Asian Petro Products and Exporters Limited | ₹42.18 Cr (FY 2025) | Vadodara, Gujarat, India | ||||
| Allastir Private Limited | ₹42.05 Cr (FY 2024) | -3.0% | Chennai, Tamil Nadu, India | |||
| Keshar Emulsion Private Limited | ₹41.86 Cr (FY 2024) | -23.0% | Ahmedabad, Gujarat, India | |||
| Hi Tech Biosciences India Private Limitedthis company | ₹41.75 Cr (FY 2025) | ₹6.03 Cr | 14.4% | 24.0% | 97 | Pune, Maharashtra, India |
| Jai Lara Drugs Private Limited | ₹41.75 Cr (FY 2025) | 9.0% | Hyderabad, Telangana, India | |||
| Polydrug Laboratories Private Limited | ₹41.72 Cr (FY 2024) | 238.0% | Mumbai, Maharashtra, India | |||
| Phanicare Pharmaceuticals Private Limited | ₹41.7 Cr (FY 2024) | -18.0% | Hyderabad, Telangana, India | |||
| Qualikems Lifesciences Private Limited | ₹41.7 Cr (FY 2025) | 13.0% | Vadodara, Gujarat, India |
To see the full peer comparison of Hi Tech Biosciences India Private Limited, buy the company report.
Auditor
Hi Tech Biosciences India Private Limited is audited by R G Mundada & co. for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| R G Mundada & co. | FY 2022 | 106685W |
Shareholding
The shareholding of Hi Tech Biosciences India Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Hi Tech Biosciences India Private Limited, buy the company report.
Charges & borrowings
Open charges
₹24.55 Cr
Satisfied charges
₹30.95 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Sep 2025 | 101171408 | Sidbi | ₹2 Cr | Open | |
| 13 Oct 2020 | 100393548 | Others | ₹22.55 Cr | Open | |
| 03 Oct 2019 | 100313053 | Axis Bank Limited | ₹4.27 Lakh | Satisfied | |
| 20 Mar 2019 | 100251262 | Sidbi | ₹75 Lakh | Satisfied | |
| 01 Nov 2017 | 100173879 | Axis Bank Limited | ₹10 Cr | Satisfied |
To see the full charge records of Hi Tech Biosciences India Private Limited, buy the company report.
Total charge records: 11 View all charges
Deals & funding
Hi Tech Biosciences India Private Limited has 9 deals on record (6 secondary share transfers, 3 funding rounds), with disclosed funding of ₹4.68 Cr; the latest was in March 2021.
Total deals
9
Secondary share transfers
6
Funding rounds
3
Disclosed funding
₹4.68 Cr
Deals on record (5 of 9)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2021 | Secondary share transfer | Undisclosed | Buyer: Raghavendra Prabhakar Gaikaiwari HUF, an individual Seller: 4 individuals |
| Apr 2016 | Secondary share transfer | Undisclosed | Seller: Jnj Finance Company Private Limited |
| Feb 2016 | Secondary share transfer | Undisclosed | Seller: Jnj Finance Company Private Limited |
| Jan 2016 | Secondary share transfer | Undisclosed | Seller: Jnj Finance Company Private Limited |
| Aug 2015 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 3 individuals |
To see the full deal history of Hi Tech Biosciences India Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Hi Tech Biosciences India Private Limited has 3 court cases on record: 1 filed by Hi Tech Biosciences India, 2 filed against it. 1 case is pending and 2 are disposed.
Total cases
3
Filed by the company
1
Filed against the company
2
Pending
1
Disposed
2
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 1 | 0 |
| High courts | 1 | 1 | 1 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Court case (COMIP) | Filed against the company by Opella Healthcare India Pvt Ltd and 1 other | Pending |
| District court, Pune, Maharashtra | Court case (Cri.Rev.App.) | Filed against the company by an individual | Disposed |
| District court, Pune, Maharashtra | Civil suit | Filed by the company against an individual | Disposed |
To see the full case history of Hi Tech Biosciences India Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Hi Tech Biosciences India Private Limited has 8 MSME Form 1 returns on record between 2014 and 2022, listing 213 overdue payments to 42 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 42)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| Offshore Accounting and Taxation Services Private Limited | |||
| an individual supplier | |||
| Advance Labs Scientific Limited | |||
| Omkar Traders |
To see the full MSME payment records of Hi Tech Biosciences India Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Hi Tech Biosciences India has 1 associated company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
1
Associated companies
Employees & EPFO
Hi Tech Biosciences India Private Limited has a workforce of 97 employees on its EPFO records as of Mar 27, 2024, across 1 active EPFO establishment.
Employee count
97
Active EPFO establishments
1
Employee growth
-2.02%
GST
Hi Tech Biosciences India has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AABCH8625A1ZV | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Hi Tech Biosciences India Private Limited, buy the company report.
Recent activity
Hi Tech Biosciences India Private Limited has 7 board changes on record since 2007: 2 appointments and 5 cessations. The latest: Sudhir Madhusudan Gadgil ceased to be Director on 23 Jul 2020.
Charges
A charge registered on 17 May 2012 via Charge ID 10358524 with Biotechnology Industry Research Assistance Council was fully satisfied on 26 Nov 2025.
Charges
A charge registered on 20 Mar 2019 via Charge ID 100251262 with Sidbi was fully satisfied on 10 Nov 2025.
AGM
Hi Tech Biosciences India Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Sidbi amounted to Rs. 2.00 Cr with Charge ID 101171408 was registered on 30 Sep 2025.
Charges
A charge registered on 29 May 2012 via Charge ID 10358853 with Biotechnology Industry Research Assistance Council was fully satisfied on 21 Apr 2025.
Filing
Hi Tech Biosciences India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pune.
Charges
A charge with Others of Rs. 22.55 Cr registered on 13 Oct 2020 with Charge ID 100393548 was modified on 28 Mar 2025.
Charges
A charge registered on 03 Oct 2019 via Charge ID 100313053 with Axis Bank Limited was fully satisfied on 15 Feb 2025.
Charges
A charge registered on 01 Nov 2017 via Charge ID 100173879 with Axis Bank Limited was fully satisfied on 05 Mar 2021.
Charges
A charge with Others amounted to Rs. 22.55 Cr with Charge ID 100393548 was registered on 13 Oct 2020.
Ceased
Sudhir Madhusudan Gadgil ceased to be Director.
Charges
A charge with Axis Bank Limited of Rs. 10.00 Cr registered on 01 Nov 2017 with Charge ID 100173879 was modified on 04 Dec 2019.
25 earlier events are in the company report.
Frequently asked questions
Hi Tech Biosciences India is an active private limited company based in Pune, Maharashtra, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 24 April 2007 (19+ years old) and is registered under CIN U24232PN2007PTC130033.
Hi Tech Biosciences India has 2 current directors:
- Raghavendra Prabhakar Gaikaiwari - Managing Director
- Shilpa Anil Wagh - Whole-Time Director
The latest financial statements of Hi Tech Biosciences India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Hi Tech Biosciences India is 27AABCH8625A1ZV, registered in Maharashtra.
The CIN (Corporate Identification Number) of Hi Tech Biosciences India is U24232PN2007PTC130033. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Hi Tech Biosciences India has 3 court cases on record: 1 filed by the company and 2 filed against it. 1 is pending. Most are in the district courts.
Hi Tech Biosciences India was incorporated on 24 April 2007, making it 19+ years old. It is registered with the Registrar of Companies, Pune.
Hi Tech Biosciences India has 9 deals on record (6 secondary share transfers, 3 funding rounds), with disclosed funding of ₹4.68 Cr; the latest was in March 2021.
The peers of Hi Tech Biosciences India by revenue are Shraddha Associates (Guj) Private Limited, Asian Petro Products and Exporters Limited, Allastir Private Limited, Keshar Emulsion Private Limited, Jai Lara Drugs Private Limited and 3 more, all in the Chemicals industry (API Manufacturers, Biosciences, Industrial Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Sudhir Madhusudan Gadgil ceased to be Director on 23 Jul 2020. Bhaskar Dattatraya Kulkarni ceased to be Director on 13 Jan 2019. Vijayalaxmi Prabhakar Gaikaiwari ceased to be Director on 31 Jan 2017. Hi Tech Biosciences India has 7 board changes on record in total.
Yes, Hi Tech Biosciences India is registered as a small enterprise under Udyam registration (number: UDYAM-MH-26-0025828).
Hi Tech Biosciences India has 8 MSME Form 1 returns on record between 2014 and 2022, listing 213 overdue payments to 42 micro and small suppliers. The latest return was filed on 30 Jan 2023.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages